Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis

CYP19A1: Aromatase excess syndrome is characterized by pre- or peripubertal onset of gynecomastia due to estrogen excess because of a gain-of-function mutation in the aromatase gene (CYP19A1). Subchromosomal recombination events including duplication, deletion, and inversion has been identified. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Shozu, Makio, Fukami, Maki, Ogata, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa UK, Ltd. 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162655/
https://www.ncbi.nlm.nih.gov/pubmed/25264451
http://dx.doi.org/10.1586/17446651.2014.926810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162655/
https://www.ncbi.nlm.nih.gov/pubmed/25264451
http://dx.doi.org/10.1586/17446651.2014.926810

Ejemplares similares